Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Melatonin may help treat hair loss and needs more research.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.